Coronavirus Inhibitors Targeting nsp16

Coronavirus Inhibitors Targeting nsp16

During the past three decades, humans have been confronted with different new coronavirus outbreaks. Since the end of the year 2019, COVID-19 threatens the world as a rapidly spreading infectious disease. For this work, we targeted the non-structural protein 16 (nsp16) as a key protein of SARS-CoV-2...

Full description

Bibliographic Details
Main Authors:	Ejlal A. Omer, Sara Abdelfatah, Max Riedl, Christian Meesters, Andreas Hildebrandt, Thomas Efferth
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Series:	Molecules
Subjects:	SARS-CoV-2 SARS-CoV-1 MERS-CoV nsp16 natural products pan-inhibitor
Online Access:	https://www.mdpi.com/1420-3049/28/3/988

Similar Items

3-(Adenosylthio)benzoic Acid Derivatives as SARS-CoV-2 Nsp14 Methyltransferase Inhibitors
by: Olga Bobileva, et al.
Published: (2023-01-01)

Highly pathogenic coronaviruses: thrusting vaccine development in the spotlight
by: Chunting He, et al.
Published: (2020-07-01)

The relation between avian coronaviruses and SARS-CoV-2 coronavirus
by: Hanan Al-Khalaifah, et al.
Published: (2022-10-01)

Contribution to pathogenesis of accessory proteins of deadly human coronaviruses
by: Jesus Hurtado-Tamayo, et al.
Published: (2023-05-01)

The biological diversity of coronaviruses: where will the new threat come from?
by: Alexandr Khaitovich, et al.
Published: (2022-05-01)

Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects
by: Przemyslaw Wielgat, et al.
Published: (2020-08-01)

Structure-Based Virtual Screening for Methyltransferase Inhibitors of SARS-CoV-2 nsp14 and nsp16
by: Kejue Wu, et al.
Published: (2024-05-01)

Antiviral Potential of <i>Antillogorgia americana</i> and <i>elisabethae</i> Natural Products against nsp16–nsp10 Complex, nsp13, and nsp14 Proteins of SARS-CoV-2: An In Silico Investigation
by: Omkar Pokharkar, et al.
Published: (2023-07-01)

SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
by: T.M. Abdelghany, et al.
Published: (2021-03-01)

Development of Coronavirus Treatments Using Neutralizing Antibodies
by: Saman Fouladirad, et al.
Published: (2021-01-01)

Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds
by: Philip L. Tzou, et al.
Published: (2020-09-01)

Bioactive natural compounds against human coronaviruses: a review and perspective
by: Yanfang Xian, et al.
Published: (2020-07-01)

Discovery of Highly Potent Small Molecule Pan-Coronavirus Fusion Inhibitors
by: Francesca Curreli, et al.
Published: (2023-04-01)

Evolutionary Dynamics and Epidemiology of Endemic and Emerging Coronaviruses in Humans, Domestic Animals, and Wildlife
by: Ariful Islam, et al.
Published: (2021-09-01)

Nucleoside Analogs and Nucleoside Precursors as Drugs in the Fight against SARS-CoV-2 and Other Coronaviruses
by: Nicola Borbone, et al.
Published: (2021-02-01)

Comment on Alfassam et al. Development of a Colorimetric Tool for SARS-CoV-2 and Other Respiratory Viruses Detection Using Sialic Acid Fabricated Gold Nanoparticles. <i>Pharmaceutics</i> 2021, <i>13</i>, 502
by: Milad Zandi, et al.
Published: (2022-09-01)

Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)
by: Francesco Sessa, et al.
Published: (2021-03-01)

Comparison and Analysis of Neutralizing Antibody Levels in Serum after Inoculating with SARS-CoV-2, MERS-CoV, or SARS-CoV Vaccines in Humans
by: Sicong Yu, et al.
Published: (2021-06-01)

Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach
by: Taimoor Khan, et al.
Published: (2022-04-01)

Recent Chronology of COVID-19 Pandemic
by: Sazada Siddiqui, et al.
Published: (2022-05-01)

Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16
by: Huan Wang, et al.
Published: (2023-12-01)

Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
by: Ujjwal Neogi, et al.
Published: (2020-04-01)

Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses
by: Srividhya Venkataraman
Published: (2022-10-01)

Molecular docking and pharmacokinetic studies of phytocompounds from Nigerian Medicinal Plants as promising inhibitory agents against SARS-CoV-2 methyltransferase (nsp16)
by: Tolulope Peter Saliu, et al.
Published: (2021-11-01)

Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01)

Comparative transcriptome analysis of SARS-CoV-2, SARS-CoV, MERS-CoV, and HCoV-229E identifying potential IFN/ISGs targets for inhibiting virus replication
by: Yuzhuang Liu, et al.
Published: (2023-12-01)

Immune Profiling of COVID-19 in Correlation with SARS and MERS
by: Bariaa A. Khalil, et al.
Published: (2022-01-01)

SARS, MERS and COVID-19-Associated Renal Pathology
by: Hristo Popov, et al.
Published: (2022-10-01)

Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections
by: Ashutosh Khaswal, et al.
Published: (2022-07-01)

Honokiol Inhibits SARS-CoV-2 Replication in Cell Culture at a Post-Entry Step
by: Clarisse Salgado-Benvindo, et al.
Published: (2023-06-01)

POTENTIAL RISK OF BRAIN DAMAGE AND POOR DEVELOPMENTAL OUTCOMES IN CHILDREN PRENATALLY EXPOSED TO SARS-COV-2: A SYSTEMATIC REVIEW
by: Marcio Leyser, et al.
Published: (2021-05-01)

Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays
by: Francesca Curreli, et al.
Published: (2021-12-01)

Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening
by: Raitis Bobrovs, et al.
Published: (2021-11-01)

Susceptibility to SARS-CoV-2 and MERS-CoV in Beagle Dogs
by: Kwang-Soo Lyoo, et al.
Published: (2023-02-01)

Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
by: Yang Yang, et al.
Published: (2024-05-01)

SARS-CoV-2 and other Coronaviruses: A matter of variations
by: Ibtesam Ghadban Auda, et al.
Published: (2023-04-01)

Emerging Mutations in Nsp1 of SARS-CoV-2 and Their Effect on the Structural Stability
by: Kejie Mou, et al.
Published: (2021-10-01)

Bispecific antibodies provide broad neutralization of emerging beta-coronaviruses by targeting ACE2 and viral spikes
by: Minghui Li, et al.
Published: (2024-12-01)

A high-throughput response to the SARS-CoV-2 pandemic
by: Lynn Rasmussen, et al.
Published: (2024-07-01)

Bio-Chemoinformatics-Driven Analysis of nsp7 and nsp8 Mutations and Their Effects on Viral Replication Protein Complex Stability
by: Bryan John J. Subong, et al.
Published: (2024-03-01)